GSK plc Cash Flows From Used In Financing Activities Continuing Operations
GSK plc (GLAXF) reported Cash Flows From Used In Financing Activities Continuing Operations of -GBP 4.73 billion for the 12-month period ending 2024-12-31, per its 20-F filed 2025-03-03.
Financial Statements › Notes
ifrs-full:CashFlowsFromUsedInFinancingActivitiesContinuingOperations · last filed 2025-03-03
| Period end | Cash Flows From Used In Financing Activities Continuing Operations 12 month |
|---|---|
| 2024-12-31 | -4.73B GBP 20-F · filed 2025-03-03 |
| 2023-12-31 | -5.64B GBP 20-F · filed 2025-03-03 |
| 2022-12-31 | -9.25B GBP 20-F · filed 2025-03-03 |
| 2021-12-31 | -7.13B GBP 20-F · filed 2024-03-05 |
| 2020-12-31 | -9.54B GBP 20-F · filed 2023-03-10 |